1. Piwnica D, Pathak A, Schäfer G, Docherty JR. In vitro safety pharmacology profiling of topical α-adrenergic agonist treatments for erythema of rosacea. Drugs R&D. 2018;18(1):87–90.
2. Kuang A, DuBois J, Ahluwalia G, Zhang S. Clinical pharmacokinetics of oxymetazoline cream following topical facial administration for the treatment of erythema associated with rosacea. Poster presentation at American Academy of Dermatology Annual Meeting, 20–24 March 2015; San Francisco, CA.
3. Kuang A, DuBois J, Attar M, Ahluwalia G. Clinical pharmacokinetics of oxymetazoline cream following topical facial administration for the treatment of erythema associated with rosacea. J Drugs Dermatol. 2018;17(2):213–20.
4. Leyden JJ. Clinical Study Report V-101-ROSE-201 (data on file). Allergan plc; 2010.
5. DuBois JC. Clinical Study Report V-101-ROSE-205 (data on file). Allergan plc; 2012.